| S1629 |
Orlistat
|
Orlistat is a general lipase inhibitor with IC50 of 122 ng/ml for PL from human duodenal juice. This compound treatment reduces proliferation, induces apoptosis and arrests cell cycle.
|
-
Cell Rep, 2025, 44(7):115901
-
Acta Pharmacol Sin, 2025, 10.1038/s41401-025-01477-y
-
J Cell Sci, 2024, 137(20)jcs262162
|
|
| S4904 |
JZL184
|
JZL 184 is the first selective inhibitor of monoacylglycerol lipase (MAGL) with IC50 of 8 nM.
|
-
Nat Chem Biol, 2022, 10.1038/s41589-022-00996-7
-
Biomed Pharmacother, 2022, 149:112798
-
J Cardiovasc Transl Res, 2022, 10.1007/s12265-022-10323-z
|
|
| S7364 |
Atglistatin
|
Atglistatin is a highly potent, and selective inhibitor of adipose triglyceride lipase (ATGL) with IC50 of 0.7 μM, high selectivity over other key metabolic lipases.
|
-
Nat Commun, 2025, 16(1):4432
-
Int J Nanomedicine, 2025, 20:9019-9030
-
J Cell Mol Med, 2025, 29(14):e70693
|
|
| S9404 |
Pristimerin
|
Pristimerin is a naturally occurring triterpenoid that has been shown to suppress the proliferation of various cancer cell lines at the concentration (IC50) range of 0.2-4 μM, including those of breast, glioma, prostate, pancreatic, ovarian, colon. This compound can inhibit monoacylglycerol lipase(MGL) with an IC50 of 93 nM through a reversible mechanism.
|
-
Cell Death Dis, 2020, 14;11(4):232
|
|
| S7457 |
XEN445
|
XEN445 is a potent and selective endothelial lipase inhibitor with IC50 of 0.237 μM.
|
|
|
| S7543 |
JW642
|
JW642 is a potent inhibitor of monoacylglycerol lipase (MAGL) that displays IC50 values of 7.6, 14, and 3.7 nM for inhibition of MAGL in mouse, rat, and human brain membranes, respectively.
|
|
|
| S9234 |
Schaftoside
|
Schaftoside, a bioactive compound found in the Herba Desmodii Styracifolii, exhibits pancreatic lipase inhibitory activity. This compound inhibits the expression of TLR4 and Myd88. It also decreases Drp1 expression and phosphorylation, and reduces mitochondrial fission.
|
|
|
| S0536 |
Ibrolipim
|
Ibrolipim (NO-1886) is an effective lipoprotein lipase (LPL) activator that increases LPL mRNA and LPL activity in adipose tissue, myocardium, and skeletal muscle.
|
|
|
| S4825 |
Pancreatin
|
Pancreatin (Pancrelipase, Pancreatic enzymes), are commercial mixtures of amylase, lipase, and protease. They are used to treat malabsorption syndrome due to pancreatic problems.(PROTEASE ACTIVITY ≥ 275 USP.u/mg;Amvlase activity ≥ 275 USP.u/mg;Lipase Activity ≥ 22 USP.u/mg)
|
|
|
| S6550 |
URB602
|
URB602 is an inhibitor of monoacylglycerol lipase (MGL), a serine hydrolase involved in the biological deactivation of the endocannabinoid 2-arachidonoyl-sn-glycerol (2-AG).
|
|
|